FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2998905839> ?p ?o ?g. }

• W2998905839 abstract "We assessed the external validity of composite indices Ankylosing Spondylitis Disease Activity Score (ASDAS), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and Assessment in SpondyloArthritis international Society (ASAS) 40 response (ASAS40) by evaluating the correlations between the changes in some patient reported outcomes (PROs) for patients with non-radiographic axial spondyloarthritis (nr-axSpA) and the changes in the scores of the composite indices.This was a post-hoc analysis of data from the EMBARK study in patients with nr-axSpA treated with etanercept. PROs were grouped according to ASDAS status (inactive [< 1.3], low [≥ 1.3 to < 2.1], high [≥ 2.1 to ≤3.5], and very high [> 3.5]), patient achievement of > 50% improvement in BASDAI (BASDAI50 responders), and > 40% improvement in ASAS (ASAS40 responders) at 104 weeks. Analyses were conducted on observed cases available at Week 104. Changes in PROs from Baseline to Week 104 were assessed using analysis of covariance with adjustment for baseline with linear contrast.Higher ASDAS disease activity at 104 weeks was associated with lower long-term improvement from baseline in PROs (e.g., total back pain [visual analog scale, cm (95% confidence interval): - 4.58 (- 4.95, - 4.21), - 3.86 (- 4.28, - 3.43), - 2.15 (- 2.68, - 1.61), and 1.30 (- 0.51, 3.12) for inactive, low, high, and very high ASDAS disease activity, respectively; Multidimensional Fatigue Inventory (MFI) general fatigue: - 4.77 (- 5.70, - 3.84), - 2.96 (- 4.04, - 1.87), - 1.00 (- 2.32, 0.31), and 2.14 (- 2.10, 6.38); all p < 0.001)]. BASDAI50 non-responders had less improvement in PROs from Baseline to Week 104 vs. responders (e.g., total back pain: - 1.61 (- 2.05, - 1.18) vs. -4.43 (- 4.69, - 4.18); MFI general fatigue: - 0.01 (- 1.12, 1.09) vs. -4.30 (- 4.98, - 3.62); all p < 0.001). ASAS40 non-responders also had less improvement in PROs from Baseline to Week 104 vs. responders (e.g., total back pain: - 1.91 (- 2.30, - 1.52) vs. -4.75 (- 5.05, - 4.46); MFI general fatigue: - 0.63 (- 1.56, 0.30) vs. -4.64 (- 5.37, - 3.91); all p < 0.001).Composite indices are valid for monitoring treatment response and adequately reflect treatment-related changes experienced by patients with nr-axSpA.ClinicalTrials.gov identifier: NCT01258738. Registered 9 December 2010." @default.
• W2998905839 created "2020-01-23" @default.
• W2998905839 creator A5002884556 @default.
• W2998905839 creator A5017179193 @default.
• W2998905839 creator A5024986694 @default.
• W2998905839 creator A5026447860 @default.
• W2998905839 creator A5041835212 @default.
• W2998905839 creator A5051671353 @default.
• W2998905839 creator A5065884210 @default.
• W2998905839 creator A5077099389 @default.
• W2998905839 creator A5089158758 @default.
• W2998905839 date "2020-01-03" @default.
• W2998905839 modified "2023-10-17" @default.
• W2998905839 title "Relationship between disease activity status or clinical response and patient-reported outcomes in patients with non-radiographic axial spondyloarthritis: 104-week results from the randomized controlled EMBARK study" @default.
• W2998905839 cites W1578120065 @default.
• W2998905839 cites W1814526147 @default.
• W2998905839 cites W1824831608 @default.
• W2998905839 cites W1857312731 @default.
• W2998905839 cites W1966756689 @default.
• W2998905839 cites W2044316531 @default.
• W2998905839 cites W2077615804 @default.
• W2998905839 cites W2103778140 @default.
• W2998905839 cites W2162319272 @default.
• W2998905839 cites W2171249245 @default.
• W2998905839 cites W2276452272 @default.
• W2998905839 cites W2612879952 @default.
• W2998905839 cites W2612907928 @default.
• W2998905839 doi "https://doi.org/10.1186/s12955-019-1260-4" @default.
• W2998905839 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6942415" @default.
• W2998905839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31900174" @default.
• W2998905839 hasPublicationYear "2020" @default.
• W2998905839 type Work @default.
• W2998905839 sameAs 2998905839 @default.
• W2998905839 citedByCount "8" @default.
• W2998905839 countsByYear W29989058392020 @default.
• W2998905839 countsByYear W29989058392021 @default.
• W2998905839 countsByYear W29989058392022 @default.
• W2998905839 countsByYear W29989058392023 @default.
• W2998905839 crossrefType "journal-article" @default.
• W2998905839 hasAuthorship W2998905839A5002884556 @default.
• W2998905839 hasAuthorship W2998905839A5017179193 @default.
• W2998905839 hasAuthorship W2998905839A5024986694 @default.
• W2998905839 hasAuthorship W2998905839A5026447860 @default.
• W2998905839 hasAuthorship W2998905839A5041835212 @default.
• W2998905839 hasAuthorship W2998905839A5051671353 @default.
• W2998905839 hasAuthorship W2998905839A5065884210 @default.
• W2998905839 hasAuthorship W2998905839A5077099389 @default.
• W2998905839 hasAuthorship W2998905839A5089158758 @default.
• W2998905839 hasBestOaLocation W29989058391 @default.
• W2998905839 hasConcept C126322002 @default.
• W2998905839 hasConcept C14184104 @default.
• W2998905839 hasConcept C159110408 @default.
• W2998905839 hasConcept C168563851 @default.
• W2998905839 hasConcept C1862650 @default.
• W2998905839 hasConcept C2776213234 @default.
• W2998905839 hasConcept C2776260265 @default.
• W2998905839 hasConcept C2777226972 @default.
• W2998905839 hasConcept C2777402515 @default.
• W2998905839 hasConcept C2777453003 @default.
• W2998905839 hasConcept C2777575956 @default.
• W2998905839 hasConcept C2778579456 @default.
• W2998905839 hasConcept C2779134260 @default.
• W2998905839 hasConcept C2779650986 @default.
• W2998905839 hasConcept C2779951463 @default.
• W2998905839 hasConcept C44249647 @default.
• W2998905839 hasConcept C67761136 @default.
• W2998905839 hasConcept C71924100 @default.
• W2998905839 hasConceptScore W2998905839C126322002 @default.
• W2998905839 hasConceptScore W2998905839C14184104 @default.
• W2998905839 hasConceptScore W2998905839C159110408 @default.
• W2998905839 hasConceptScore W2998905839C168563851 @default.
• W2998905839 hasConceptScore W2998905839C1862650 @default.
• W2998905839 hasConceptScore W2998905839C2776213234 @default.
• W2998905839 hasConceptScore W2998905839C2776260265 @default.
• W2998905839 hasConceptScore W2998905839C2777226972 @default.
• W2998905839 hasConceptScore W2998905839C2777402515 @default.
• W2998905839 hasConceptScore W2998905839C2777453003 @default.
• W2998905839 hasConceptScore W2998905839C2777575956 @default.
• W2998905839 hasConceptScore W2998905839C2778579456 @default.
• W2998905839 hasConceptScore W2998905839C2779134260 @default.
• W2998905839 hasConceptScore W2998905839C2779650986 @default.
• W2998905839 hasConceptScore W2998905839C2779951463 @default.
• W2998905839 hasConceptScore W2998905839C44249647 @default.
• W2998905839 hasConceptScore W2998905839C67761136 @default.
• W2998905839 hasConceptScore W2998905839C71924100 @default.
• W2998905839 hasFunder F4320307765 @default.
• W2998905839 hasIssue "1" @default.
• W2998905839 hasLocation W29989058391 @default.
• W2998905839 hasLocation W29989058392 @default.
• W2998905839 hasLocation W29989058393 @default.
• W2998905839 hasLocation W29989058394 @default.
• W2998905839 hasLocation W29989058395 @default.
• W2998905839 hasLocation W29989058396 @default.
• W2998905839 hasOpenAccess W2998905839 @default.
• W2998905839 hasPrimaryLocation W29989058391 @default.
• W2998905839 hasRelatedWork W1581346817 @default.
• W2998905839 hasRelatedWork W2147166948 @default.
• W2998905839 hasRelatedWork W2162960264 @default.
• W2998905839 hasRelatedWork W2170809136 @default.
• W2998905839 hasRelatedWork W2408844222 @default.

• next